Staged approach to partial breast reconstruction to avoid mastectomy in women with breast cancer.
Pankaj G Roy, Alexandra A Tenovici
https://pubmed.ncbi.nlm.nih.gov/28861373/Actively Recruiting
Led by Cambridge University Hospitals NHS Foundation Trust · Updated on 2024-12-11
1001
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to understand the outcomes after partial breast reconstruction using chest wall perforator flaps CWPF following breast conservation surgery in women with early-stage breast cancer. It focuses on gathering patient demographics, tumor characteristics, and treatment details to evaluate clinical and patient-reported effects of this surgical approach. Participants undergo partial breast reconstruction with CWPF as part of their breast conservation surgery. The study observes surgical details such as flap types and operative data, as well as oncological treatments including systemic therapies and radiotherapy. Surgeons involved have experience with at least 10 CWPF procedures, and centers plan to complete at least 10 cases annually. During the study, researchers collect information on surgical complications within 30 days, oncological clearance up to 12 months, revisional surgeries up to 36 months, cancer recurrence, and survival up to 36 months. Patient data such as age, BMI, comorbidities, and tumor location are recorded. The study monitors participants over time to assess both clinical outcomes and patient experiences related to this reconstructive surgery.
CONDITIONS
PARTial BREast RECONstruction With Chest Wall Perforator Flap
A
Amit Agrawal, DM, FRCS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor
Oxford University Hospitals NHS Trust
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 30 days
Participants undergo partial breast reconstruction using chest wall perforator flap and receive immediate post-operative care.
Approximately 1 to 3 visits during the first 30 days after surgery
Duration - Up to 36 months
Participants are monitored for oncological clearance, surgical complications, and potential revisional surgery over time.
Periodic visits as per clinical follow-up schedule
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Pankaj G Roy, Alexandra A Tenovici
https://pubmed.ncbi.nlm.nih.gov/28861373/Emanuele Garreffa, Luke Hughes-Davies, Simon Russell...
https://pubmed.ncbi.nlm.nih.gov/32284305/Patricia J A M Brouwers, Erik van Werkhoven, Harry Bartelink...
https://pubmed.ncbi.nlm.nih.gov/29980320/Moustapha Hamdi, Koenraad Van Landuyt, Stan Monstrey...
https://pubmed.ncbi.nlm.nih.gov/15308400/Amit Agrawal
https://pubmed.ncbi.nlm.nih.gov/30710399/C Navin, A Agrawal, K M Kolar
https://pubmed.ncbi.nlm.nih.gov/17180559/A Agrawal, L Romics, D Thekkinkattil...
https://pubmed.ncbi.nlm.nih.gov/37544090/Emanuele Garreffa, Icro Meattini, Charlotte E Coles...
https://pubmed.ncbi.nlm.nih.gov/37061072/Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor
Oxford University Hospitals NHS Trust
Collaborating Sponsor